Friedrichs, M. (2023). A web-based annotation tool for clinical trial failure reasons. GMS Medizinische Informatik, Biometrie Und Epidemiologie, 19, Doc02. doi: 10.3205/mibe000241

Filter:

Trial ID Phase Status Type
Results Reported Result Refs Exist Enrollment From To
Free Text
Annotations

7805 Trials matched filter criteria

Status:   Withdrawn   Suspended   Terminated
Trial Updated /
Type
Status Phase Were
Results
Reported
Reported
Actual
Enrollment
(MeSH) Terms Why Stopped
Limitations And Caveats
Annotator decisions
NCT03224923
Details
2019-07-19
Interventional
45 
Aspirin Clopidogrel Ticagrelor
Antiplatelet Th… Percutaneous Co… Stable Coronary… Ticagrelor
Competing study to be started in November 2018
-
NCT03061838
Details
2019-07-19
Interventional
18 
Rituximab
Arthritis Arthritis, Rheu… Rheumatoid Arth…
Sponsor's decision
-
NCT02952989
Details
2019-07-19
Interventional
147 
Pembrolizumab
Adenocarcinoma Breast Neoplasm… Carcinoma Carcinoma, Non-… Carcinoma, Rena… Carcinoma, Squa… Colorectal Neop… Neoplasms Squamous Cell C… Urinary Bladder… Carcinoma, Squa… Gastric Adenoca… Gastroesophagea… Urinary Bladder…
Due to overall benefit/risk profile
-
NCT03393273
2017-001446-10
Details
2019-07-17
Interventional
20 
Elotuzumab
Multiple Myelom… Neoplasms, Plas…
Investigator decision in accordance with the promotor
-
NCT02579187
Details
2019-07-17
Interventional
10 
Anesthetics
Tooth Extractio…
withdrawn study from IRB
-
NCT00455143
Details
2019-07-17
Interventional
427 
Dexmedetomidine
Cognitive Dysfu… Delirium Emergence Delir… Postoperative C… PD POCD Postoperative C… Postoperative D…
Pilot study initiated to provide support data for main grant GCO 06-0217 funded. only baseline characteristic data collected. no results for this study.
Investigator passed away. Study team no longer at institution. Study material not available.
NCT02713828
Details
2019-07-16
Interventional
1/213 
Antibodies, Mon… Glembatumumab v…
Carcinoma Carcinoma, Squa… Lung Neoplasms Squamous Cell C…
Company discontinued further development of study drug for this indication
-
NCT01875237
Details
2019-07-16
Interventional
1/23 
Alemtuzumab Fludarabine Fludarabine pho… Melphalan Methotrexate Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Tacrolimus
Myeloproliferat… Suicide Leukemia Myeloma Myeloproliferat…
-
-
NCT02294786
Details
2019-07-15
Interventional
262 
Capecitabine Lapatinib Octreotide
Diarrhea Cancer
-
-
NCT02010437
Details
2019-07-15
Interventional
40 
Sodium Tetradec…
Varicose Veins Venous Insuffic… Superficial Ven…
Study design has been substantially revised and a new registration will be made in the future.
-
NCT00439374
Details
2019-07-15
Interventional
3657 
11-hydroxyproge… 17 alpha-Hydrox…
Premature Birth Cervical Length Preterm Deliver…
Halted by NICHD after recommendation by DSMC to stop for futility
-
NCT04018417
Details
2019-07-12
Interventional
2/30 
Amphotericin B Liposomal ampho…
Fuchs' Endothel…
Reconsidered significance in light of newly published in vitro data.
-
NCT02750930
Details
2019-07-12
Interventional
48 
rGLP-1 protein
Diabetes Mellit… Diabetes Mellit…
The termination was result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct
-
NCT03710044
2018-000229-30
Details
2019-07-11
Interventional
40 
Cyclosporine Cyclosporins
Dermatitis Dermatitis, Ato… Eczema Atopic Dermatit…
Strategic decision
-
NCT01957709
Details
2019-07-10
Interventional
18 
Interferon-gamm… Interferons
Liposarcoma Liposarcoma, My… Sarcoma Sarcoma, Synovi… Myxoid Liposarc… Round Cell Lipo… Synovial Sarcom…
Enough samples were collected for data analysis.
Early termination of trial due to collection of enough data necessary to complete analysis.
NCT00242359
Details
2019-07-10
Interventional
40 
Omalizumab
Asthma Allergy Induced…
could not find subject population
-
NCT02262169
Details
2019-07-09
Interventional
332 
Omeprazole
Peptic Ulcer Ulcer Non-Bleeding Pe…
This study was terminated due to internal technical issues at study site
-
NCT02904304
Details
2019-07-08
Interventional
3-
Desloratadine Ibuprofen Oxymetazoline Phenylephrine
Common Cold Cold
the viability of the study is being analyzed
-
NCT02853578
Details
2019-07-08
Interventional
3-
Budesonide
Asthma
The viability of the study is being analyzed
-
NCT02481180
Details
2019-07-08
Interventional
136 
Immunoglobulin … T0001
Arthritis Arthritis, Rheu… Rheumatoid Arth…
-
-